[Drugs inhibiting the function of oncogene products, especially protein tyrosine kinases].
Akiyama
T
T
Ogawara
H
H
D000818:Animals; D016227:Benzoquinones; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D005419:Flavonoids / Q000494:pharmacology*; D019833:Genistein; D006873:Hydroquinones / Q000494:pharmacology*; D007529:Isoflavones / Q000494:pharmacology*; D047029:Lactams, Macrocyclic; D009857:Oncogenes; D010743:Phospholipids / Q000378:metabolism; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011809:Quinones / Q000494:pharmacology*; D017828:Rifabutin / Q000031:analogs & derivatives
D016227:Benzoquinones; D005419:Flavonoids; D006873:Hydroquinones; D007529:Isoflavones; D047029:Lactams, Macrocyclic; D010743:Phospholipids; D011809:Quinones; D017828:Rifabutin; C020754:herbimycin; D019833:Genistein; D011505:Protein-Tyrosine Kinases; C048212:erbstatin